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Abstract
Background: Previous studies suggested increased cancer incidence and mortality in workers
exposed to solvents and other chemicals in computer manufacturing jobs. Most previous studies
were of small cohorts and findings were inconsistent. A lawsuit involving a large U.S. company
produced a data file for analysis. This study sought to elucidate patterns of mortality in workers
who were engaged manufacturing computers and related electronic components in the largest
database available to date.
Methods: A proportional mortality and proportional cancer mortality analysis of deaths in eligible
workers between 1969 and 2001 was carried out, with U.S. population mortality data as the
standard for comparison. Mortality and work history data was from corporate mortality and work
history files produced during litigation and standard U.S. and state mortality files. The study base
comprised 31,941 decedents who died between 1969 and 2001, who had worked for at least five
years and whose death information was collected in the corporate mortality file. Proportional
mortality ratios (PMRs) and Proportional Cancer Mortality Ratios (PCMRs) and their 95%
confidence intervals were computed for 66 causes of death in males and females.
Results: PMRs for all cancers combined were elevated in males (PMR = 107; 95% CI = 105–109)
and females (PMR = 115; 95% CI = 110–119); several specific cancers and other causes of death
were also significantly elevated in both males and females. There were reduced deaths due to non-
malignant respiratory disease in males and females and heart disease in females; several specific
cancers and other causes of death were significantly reduced in both males and females.
Proportional cancer mortality ratios (PCMRs) for brain and central nervous system cancer were
elevated (PCMR = 166; 95% CI = 129–213), kidney cancer (PCMR = 162; 95% CI = 124–212),
melanoma of skin (PCMR = 179; 95% CI = 131–244) and pancreatic cancer (PCMR = 126; 95% CI
= 101–157) were significantly elevated in male manufacturing workers. Kidney cancer (PCMR =
212; 95% CI = 116–387) and cancer of all lymphatic and hematopoietic tissue (PCMR = 162; 95%
CI = 121–218) were significantly elevated in female manufacturing workers.
Conclusion: Mortality was elevated due to specific cancers and among workers more likely to be
exposed to solvents and other chemical exposures in manufacturing operations. Due to lack of
individual exposure information, no conclusions are made about associations with any particular
agent.
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In 2002, plaintiffs' attorneys in a lawsuit obtained compu-
terized files of deaths and work histories for US employees
of a large company which manufactured electronic office
equipment; mainframe and personal computers; compu-
ter parts, components, and accessories; and software prod-
ucts. The files contained data on employees who had
qualified for pension and death benefits and died in the
US between the years 1969 and 2001. A unique identifier
was included in both files so that death and work history
data for individual decedents could be linked.
Few studies of workers in computer manufacturing and
semiconductor fabrication are available in the published
literature. A study of workers at a Scottish semiconductor
plant was conducted by the government occupational
health authority in 2001 [1,2]. This study showed statisti-
cally significant excesses of lung, stomach, and breast can-
cers among females and an excess of brain cancer among
males; however, the number of employees in this plant
was relatively small and the number of cases of cancer was
limited. Recently, an update of a UK semiconductor work-
ers study was published which was also small and had few
significant findings with regard to cancer. A previous
excess incidence of melanoma persisted in the update,
along with excess rectal and pancreatic cancer in females
[3]. Two studies of workers who manufactured main
boards and integrated circuits in an electronics company
in Taiwan were published [4,5]. In the cancer incidence
analysis there was a significant excess of breast cancer in
female electronics company workers when compared to
two other groups of industrial workers [5]. An analysis of
mortality in three U.S. semiconductor and storage device-
manufacturing plants identified significant excess central
nervous system cancer in one plant and excess prostate
cancer in workers in another plant [6].
There are a variety of exposures to chemicals, metals
(especially arsenic, nickel and chromium), and electro-
magnetic fields (especially ultraviolet light, radiofre-
quency, and, in one process, x-ray radiation) in computer
and semiconductor manufacturing [7]. There have been
many studies of workers with these exposures in other
industries. For example, trichloroethylene is used in many
industries and there is a large literature on its health
effects [8]. Similarly, the health effects of methylene chlo-
ride, isopropyl alcohol, methyl ethyl ketone, Freon, as
well as metals and electromagnetic radiation have been
studied in other groups of workers and in experimental
animals [9,10]. Furthermore, various US and interna-
tional agencies have classified several of these chemicals
as to their carcinogenicity [11,12].
Based upon the available literature, workers exposed to
the chemicals and processes in computer and semicon-
ductor manufacturing would be expected to have elevated
mortality from non-Hodgkin's lymphoma [8,11], brain
cancer [9], kidney cancer [8,11], lung cancer [2,11], and
breast [5] cancer. Additionally, exposures in the computer
and semiconductor manufacturing industries are complex
and have changed as new processes and materials were
introduced. Thus, the mortality experience of computer
and semiconductor manufacturing workers would be
expected to vary over time due to changing exposures.
We evaluated these expectations and examined the mor-
tality among US employees of a large computer manufac-
turing company by calculating overall and sex-, age-, and
time-specific proportional mortality ratios (PMRs) and
proportional cancer mortality ratios (PCMRs). We per-
formed analyses for all eligible decedents and the sub-
group of decedents who were ever employed 30 days or
more in manufacturing.
Methods
The context of this analysis is unusual because the data
were obtained as part of litigation and the company's
attorneys resisted making the files available. A court order
forced the production of the files, and minimal documen-
tation was provided about the content and coding of the
files. Due to the context in which we received these data,
we were not able to obtain additional documentation,
access the original or complementary data, or contact
company personnel knowledgeable about the data. Since
we could not resolve problems in the data, we spent con-
siderable time developing logical rules for handling
incomplete and apparently erroneous information. These
constraints limited the data available for subgroup analy-
ses.
Corporate Mortality File
At the time it was provided to plaintiffs' attorneys, the IBM
Corporate Mortality File (CMF) maintained by the com-
pany had 33,730 records. These records were for
decedents who had been employed for five years or more,
who were actively employed or receiving retirement or
disability benefits at time of death, and whose families
had filed a claim for death benefits. CMF data required for
analysis were the identifier, sex, birth date, death date, and
underlying cause of death.
We reviewed the numbers of deaths by year of death.
Based on the apparent degree of completeness of the CMF
by year of death, we defined the study period as 1969–
2001. We excluded duplicate records and records for
which the sex, birth date, and/or death date remained
unknown or discrepant. Of the 33,730 records in the
CMF, 1,456 records were excluded for these reasons.
Processing of the work history data (see below) identified
20 additional CMF records with discrepant birth and/orPage 2 of 10
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excluded 313 CMF records for which the year of death was
before 1969 or after 2001.
The final number of CMF records used for analysis was
31,941 and comprised 27,272 males and 4,669 females.
Work History Data
The work history data set had a total of 586,258 records
representing 18,928 decedents. Work history data
required for analysis were the identifier, effective date,
position code, location code, and text notes indicating a
key employment event such as leave of absence, return
from leave of absence, separation, retirement, or death.
We added the birth and death dates from the CMF to the
work history data set. We then identified irrelevant, miss-
ing, invalid, and inconsistent work history data to the
extent feasible.
We deleted all work history records for decedents that
were excluded from the CMF (see above). Likewise, we
deleted all work history records with irrelevant, missing,
invalid or inconsistent data. Upon completion of these
steps, the work history data set included a total of 375,563
records representing 10,219 decedents. There did not
appear to be any systematic pattern in the missing data
that would produce bias in the analysis of this subset of
decedents.
Cause of Death Coding
The underlying causes of death were coded to the Ninth
Revision of the International Classification of Diseases
(ICD 9).
Comparison Population
We selected the US as the most appropriate comparison
population for the overall CMF analyses and we used it as
the comparison population for the exposure subgroup
analyses for consistency. We obtained cause-, sex-, age-,
and time-specific mortality data, adjusted to ICD 9, for the
US comparison population from the Mortality and Popu-
lation Data System (MPDS) at the University of Pittsburgh
[13]. We used default categories for sex, age, and time, and
default and "custom" categories for cause of death. The
mortality data were not categorized by race because race
was not known for the decedents included in the CMF.
Analysis
We analyzed the data with the Occupational Cohort Mor-
tality Analysis Program (i.e., OCMAP-PLUS version 3.10)
software package from the University of Pittsburgh [13].
In addition to the 63 OCMAP-PLUS default cause of death
categories, we defined the following six "custom" cause of
death categories: non-Hodgkin's lymphoma, multiple
myeloma, diseases of the nervous system, multiple sclero-
sis, Parkinson's disease, and amyotrophic lateral sclerosis.
Standardized proportional mortality ratios (PMRs) were
calculated from the ratio of the observed number of
deaths due to a particular cause among the workers to the
expected number of deaths based on the age-, sex-, time-,
and cause-specific proportional mortalities of the US pop-
ulation. The expected number of deaths was computed by
multiplying the proportional mortalities of the US popu-
lation by the total number of deaths for the workers. The
PMRs were standardized on age, sex, and time. Standard-
ized proportional cancer mortality ratios (PCMRs) also
were calculated. For the PCMRs, site-specific cancer pro-
portional mortality was computed as a proportion of all
cancer mortality. The underlying cause of death was used
for calculation of the PMRs and PCMRs. Workers with an
unknown cause of death were included in the "all causes
of death" and "unknown causes" categories. The associ-
ated 95% Poisson confidence intervals (95% CIs) for the
PMRs and PCMRs were calculated as well.
Exposure Subgroups
We defined the following exposure subgroups for both
men and women:
• ever worked in manufacturing for 30 days or more;
• ever worked at a selected California, Minnesota, New
York and Vermont location for 30 days or more.
The latter four state sub-groups were defined for analyses
of specific plants of interest in the litigation (data not
shown).
Results
The number of decedents and the percent of decedents
with available and usable work history information are
shown in Table 1 by year of death and sex. Of the 27,272
male decedents, 9,219 (33.8%) had work histories. For
the 4,669 female decedents, 1,000 (21.4%) had work his-
tories. In general, work history information was most
complete for the years 1980 – 1999 and was more com-
plete for men than women. There were 3,652 male and
723 female decedents whose work history information
indicated that they worked 30 days or more in manufac-
turing.
The all cause average age at death was 64.5 years for male
decedents and 63.4 for female decedents. The all cancer
average age at death was 63.9 years for male decedents
and 59.5 for female decedents.
Cause-specific PMRs and 95% CIs for male decedents in
the CMF were calculated and the results for major causesPage 3 of 10
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deaths from all causes. The PMR for all cancers was signif-
icantly greater than 100. There were 7,697 cancer deaths
and 7,206 were expected (PMR = 107; 95% CI = 105,
109). This excess was due to statistically significant
excesses for cancer of the digestive organs and perito-
neum, testicular and other male genital cancer, kidney
cancer, malignant melanoma of the skin, brain and cen-
tral nervous system cancer, thyroid and other endocrine
cancer, and lymphatic and hematopoietic cancer.
In addition, statistically significant excesses were observed
for benign neoplasms, nervous system diseases, ischemic
heart disease, and all other causes of death, although the
excess for ischemic heart disease was quite small. Statisti-
cally increased PMRs for multiple sclerosis, Parkinson's
disease, and amyotrophic lateral sclerosis contributed to
the excess for diseases of the nervous system. There also
were deficits of several causes of death as estimated by the
PMR method.
In Table 3, we present the cause-specific PCMRs and 95%
CIs for males in the CMF. There were 7,697 deaths from
all cancers in this group. Except for testicular and other
male genital organ cancer, all of the significantly increased
PMRs for specific cancers also had significantly increased
PCMRs, but the magnitudes of the PCMRs were less than
those for the PMRs. The testicular cancer PMR was statisti-
cally significantly increased, whereas the PCMR was not
(PCMR = 91; 95% CI = 63, 130).
The cause-specific PMRs and 95% CIs for the 4,669 female
decedents in the CMF also were calculated and the results
for major causes of death are summarized in Table 4. The
PMR for all cancers was significantly greater than 100 for
women as well. There were 1,667 cancer deaths and 1,454
were expected (PMR = 115; 95% CI = 110, 119). This
excess was due to statistically significant excesses for respi-
ratory system cancer, breast cancer, cancer of other female
genital organs, brain and central nervous system cancer,
and lymphatic and hematopoietic cancer. A statistically














1969 241 1 0.4 28 0 0.0
1970–1974 1,758 6 0.3 169 0 0.0
1975–1979 2,246 135 6.0 329 11 3.3
1980–1984 3,135 1,100 35.1 520 108 20.8
1985–1989 4,325 2,089 48.3 754 252 33.4
1990–1994 5,370 2,520 46.9 909 255 28.1
1995–1999 7,386 3,097 41.9 1,377 343 24.9
2000–2001 2,811 271 9.6 583 31 5.3
TOTAL 27,272 9,219 33.8 4,669 1,000 21.4
Table 2: Cause-Specific Proportional Mortality Ratios (PMRs) for Males
Cause Of Death Observed Expected PMR 95% CI
All Causes of Death 27,272 27,272.00 100.0 --- ---
All Malignant Neoplasms 7,697 7,206.21 106.8† 104.8 108.8
Cancer of Pancreas 441 351.78 125.4† 114.3 137.5
Cancer of Kidney 265 181.06 146.4† 129.9 164.9
Cancer of Central Nervous System 355 185.11 191.8† 173.2 212.3
Malignant Melanoma of Skin 221 115.38 191.5† 168.3 218.0
Non-Hodgkin's Lymphoma 395 262.59 150.4† 136.5 165.8
All Heart Disease 9,044 9,228.90 98.0† 96.4 99.6
Non-malignant Respiratory Disease 1636 2,131.06 76.8† 73.3 80.4
All External Causes of Death 1,809 2,440.60 74.1† 71.3 77.0
Male Corporate Mortality File deaths compared to male U.S. deaths due to all causes, 1969–2001.
† = p < 0.05Page 4 of 10
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death. As in males, there were statistically significant defi-
cits for several causes as estimated by the PMR method.
In Table 5, the cause-specific PCMRs and 95% CIs for
females in the CMF are shown. There were 1,667 deaths
from all cancers in this group. The PCMR for breast cancer
(PCMR = 115; 95% CI = 106, 125) remained significantly
elevated, while the PCMRs for several other cancers were
no longer elevated compared to their respective PMRs.
These cancers included the following: respiratory system
cancer; cancer of the trachea, bronchus, and lung; cancer
of other female genital organs; brain and central nervous
system cancer; lymphatic and hematopoietic cancer;
leukemia and aleukemia; non-Hodgkin's lymphoma; and
all other lymphatic and hematopoietic cancer. Further-
more, the PCMRs for cancer of the buccal cavity and phar-
ynx, and cancer of the digestive organs and peritoneum
were significantly decreased compared to the correspond-
ing PMRs.
In Table 6, PCMRs are presented for males in the CMF
who worked in manufacturing for 30 days or more. There
were 1,180 deaths from all cancers in this group. In com-
parison to the PMRs, only the PCMRs for pancreatic can-
cer (PCMR = 126; 95% CI = 101, 157), kidney cancer
(PCMR = 162; 95% CI = 124, 212), malignant melanoma
of the skin (PCMR = 179; 95% CI = 131, 244), and brain
and central nervous system cancer (PCMR = 166; 95% CI
= 129, 213) remained statistically significant.
In Table 7, PCMRs are presented for female manufactur-
ing workers. All cancers accounted for 302 deaths in this
group. The PCMRs for kidney cancer and the other lym-
phatic and hematopoietic cancers (i.e., leukemia and
aleukemia and all other lymphatic and hematopoietic
cancer) were significantly increased in this subgroup.
In Fig. 1, we compare the PCMRs for males and females
combined who worked 30 days or more in manufacturing
in the CMF analyses with the SMRs from the combined
Table 3: Cause-Specific Proportional Cancer Mortality Ratios (PCMRs) for Males
Cause Of Death Observed Expected PCMR 95% CI
All Malignant Neoplasms 7,697 7,697.00 100.0 --- ---
Cancer of Buccal Cavity & Pharynx 126 189.63 66.4† 56.0 78.8
Cancer of Digestive Organs & Peritoneum 2,025 1,868.27 108.4† 104.4 112.6
Cancer of Esophagus 239 243.68 98.1 86.6 111.1
Cancer of Stomach 225 239.30 94.0 82.7 106.9
Cancer of Large Intestine 780 628.97 124.0† 116.0 132.6
Cancer of Rectum 135 130.29 103.6 87.7 122.5
Cancer of Biliary Passages & Liver 160 200.03 80.0† 68.7 93.2
Cancer of Pancreas 441 372.21 118.5† 108.2 129.8
Cancer of All Other Digestive Organs 45 47.42 94.9 70.9 127.0
Cancer of Respiratory System 2,220 2,837.10 78.2† 75.7 80.8
Cancer of Larynx 44 98.28 44.8† 33.6 59.6
Cancer of Trachea, Bronchus, & Lung 2,151 2,711.92 79.3† 76.7 82.0
Cancer of All Other Respiratory Organs 25 26.90 92.9 62.8 137.4
Cancer of Breast 12 9.51 126.1 71.8 221.8
Cancer of Prostate 648 603.95 107.3 99.9 115.3
Cancer of Testes & Other Male Genital Organs 28 30.85 90.8 63.2 130.3
Cancer of Kidney 265 194.74 136.1† 120.9 153.2
Cancer of Bladder & Other Urinary Organs 194 172.61 112.4 97.8 129.1
Malignant Melanoma of Skin 221 138.23 159.9† 140.6 181.8
Cancer of Eye 2 3.96 50.5 13.0 196.5
Cancer of Brain and Other Central Nervous System 355 219.24 161.9† 146.4 179.1
Cancer of Thyroid & Other Endocrine Glands 43 22.50 191.1† 142.5 256.2
Cancer of Bone 20 20.44 97.8 63.3 151.2
Cancer of All Lymphatic, Hematopoietic Tissue 938 761.22 123.2† 116.1 130.8
Lymphosarcoma & Reticulosarcoma 65 49.84 130.4† 102.6 165.8
Hodgkin's Disease 41 47.21 86.8 64.4 117.1
Leukemia & Aleukemia 327 288.48 113.4† 102.0 126.0
Cancer of All Other Lymphopoietic Tissue 505 375.72 134.4† 123.5 146.3
Non-Hodgkin's Lymphoma 395 291.46 135.5† 123.1 149.2
Multiple Myeloma 169 126.93 133.1† 114.7 154.5
All Other Malignant Neoplasms 598 631.10 94.8 87.8 102.3
Male Corporate Mortality File deaths compared to male U.S. cancer deaths, 1969–2001.
† = p < 0.05Page 5 of 10
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Table 2]. Although there is considerable overlap in the
two studies, the time periods, numbers of deaths, and
sources of information are different, so only a graphical
comparison of results for specific cancers is presented.
Discussion
We found an overall excess mortality for all cancer in
males and females in the entire corporate mortality data.
The PMRs for all sites were significantly elevated when
comparing the computer company workers to the US pop-
ulation experience during the time period 1969–2001. In
addition, there was excess mortality in both males and
females due to several types of cancer.
Because of the potential for lowered mortality due to
major causes such as ischemic heart disease or respiratory
disease, we calculated PCMRs, which focused specifically
on cancer mortality. The PCMR is less susceptible to dis-
tortion by the "healthy worker effect," and focuses on the
health outcome of most interest in these analyses. The
results of the PCMR analyses in males were for the most
part quite similar to the PMR results for the same cancers.
For cancer of the testis, however, the PCMR was 91 (95%
CI 63,130) as compared to a PMR of 146. In females, the
PCMR for breast cancer was significantly elevated, while
the PCMRs for several other cancers were not, compared
to their respective PMRs. A recent SMR analysis of workers
at three of the plants over an earlier time period in this
large company [6] indicated that there was a substantial
"healthy worker effect" although the data to do an evalu-
ation of this in our dataset was not available to us. From a
graphic comparison of the SMRs from one table in this
analysis with our nearest equivalent PCMR results, pro-
Comparison of SMRs and PCMRsFigure 1
Comparison of SMRs and PCMRs. Comparison of SMRs (triangles) for selected cancers from Table 2 in ref. 6 with PCMRs 
(squares) for manufacturing plant decedents. The vertical lines are the Upper and Lower 95% Confidence Limits of the SMRs 
and PCMRs. All data are for males and females combined except for prostate, breast and lung cancer; SMRs are for the years 
1965–1999 and for those who died 15 or more years since first employment. PCMRs are for the years 1969–2001 and for 
those who died ten or more years since first employment.
Table 4: Cause-Specific Proportional Mortality Ratios (PMRs) for Females
Cause Of Death Observed Expected PMR 95% CI
All Causes of Death 4,669 4,669.00 100.0 --- ---
All Malignant Neoplasms 1,667 1,454.39 114.6† 110.3 119.1
Cancer of Pancreas 71 66.29 107.1 85.0 134.9
Cancer of Breast 418 306.15 136.5† 124.6 149.6
Cancer of Kidney 31 22.91 135.3 95.4 192.0
Cancer of Central Nervous System 51 38.53 132.4† 100.8 173.8
Malignant Melanoma of Skin 26 19.61 132.6 90.5 194.3
Non-Hodgkin's Lymphoma 70 50.16 139.5† 110.7 176.0
All Heart Disease 998 1,229.92 81.1† 77.1 85.5
Non-malignant Respiratory Disease 279 348.41 80.1† 71.6 89.6
All External Causes of Death 288 341.75 84.3† 76.2 93.2
Female Corporate Mortality File deaths compared to female U.S. deaths due to all causes, 1969–2001.
† = p < 0.05Page 6 of 10
(page number not for citation purposes)
Environmental Health: A Global Access Science Source 2006, 5:30 http://www.ehjournal.net/content/5/1/30vided in Figure 1, it appears that the overall pattern is very
similar in the two mortality analyses.
Cancer mortality patterns in the general population over
the time period 1969–2001 changed somewhat. For
example, lung cancer mortality increased dramatically in
US females during this time period while cervical cancer
mortality decreased. In males, lung cancer mortality
increased in the early part of the time period, but began to
decline in the 1990s. Accordingly, we examined the work-
ers' mortality experience in five-year time intervals, and
we looked at patterns by five-year age groups during these
intervals. The excesses of some cancers were greater in the
younger age groups and in the 1970s and 1980s rather
than the latter years of the study period. These patterns are
consistent with a work-related cancer mortality effect that
has diminished in recent years.
Additional analyses of specific subgroups of decedents
were carried out, primarily because of concerns that toxic
exposures used in manufacturing, such as solvents, met-
als, electromagnetic radiation, and the components of
photoresist might be associated with increased cancer
mortality. For example, numerous halogenated solvents
are used in computer manufacturing [1,2,10] and some of
these are associated with increased risk of kidney cancer
and cancer of the lymphatic and hematopoietic tissue in
workers [8]. No information on individual exposure to
specific chemicals or processes was available for this anal-
ysis. Accordingly, we examined the mortality patterns
among decedents for whom work histories were available
and grouped them into manufacturing jobs and presented
results for this sub-group.
The overall PMR and PCMR analyses for manufacturing
workers revealed a pattern that was similar to the pattern
in all workers combined. In most instances, the PMRs and
Table 5: Cause-Specific Proportional Cancer Mortality Ratios (PCMRs) for Females
Cause Of Death Observed Expected PCMR 95% CI
All Malignant Neoplasms 1,667 1,667.00 100.0 --- ---
Cancer of Buccal Cavity & Pharynx 9 19.08 47.2† 25.0 88.9
Cancer of Digestive Organs & Peritoneum 289 323.00 89.5† 80.8 99.1
Cancer of Esophagus 13 16.13 80.6 47.0 138.3
Cancer of Stomach 34 32.53 104.5 74.9 145.7
Cancer of Large Intestine 120 133.00 90.2 76.1 107.0
Cancer of Rectum 18 22.61 79.6 50.4 125.8
Cancer of Biliary Passages & Liver 23 33.92 67.8 45.4 101.3
Cancer of Pancreas 71 72.74 97.6 77.8 122.5
Cancer of All Other Digestive Organs 10 11.11 90.0 48.6 166.9
Cancer of Respiratory System 376 365.12 103.0 94.3 112.4
Cancer of Larynx 1 5.77 17.3† 3.1 97.4
Cancer of Trachea, Bronchus, & Lung 373 355.71 104.9 96.0 114.6
Cancer of All Other Respiratory Organs 2 3.64 55.0 14.1 215.0
Cancer of Breast 418 362.40 115.3† 106.1 125.4
All Uterine Cancers 53 94.10 56.3† 43.6 72.8
Cancer of Cervix Uteri 23 55.35 41.6† 28.3 61.0
Cancer of Other Female Genital Organs 116 104.90 110.6 92.7 131.9
Cancer of Kidney 31 25.81 120.1 84.7 170.2
Cancer of Bladder & Other Urinary Organs 13 15.55 83.6 48.8 143.4
Malignant Melanoma of Skin 26 24.47 106.2 72.7 155.4
Cancer of Eye 0 .86 --- --- ---
Cancer of Brain and Other Central Nervous System 51 46.92 108.7 83.0 142.3
Cancer of Thyroid & Other Endocrine Glands 10 6.64 150.6 81.5 278.3
Cancer of Bone 2 4.13 48.5 12.6 186.6
Cancer of All Lymphatic, Hematopoietic Tissue 167 149.40 111.8 96.9 129.0
Lymphosarcoma & Reticulosarcoma 8 8.70 92.0 46.2 183.0
Hodgkin's Disease 8 9.79 81.7 41.5 161.0
Leukemia & Aleukemia 64 56.27 113.7 89.6 144.4
Cancer of All Other Lymphopoietic Tissue 87 74.65 116.5 95.0 143.0
Non-Hodgkin's Lymphoma 70 57.18 122.4 97.3 154.0
Multiple Myeloma 25 25.20 99.2 67.3 146.3
All Other Malignant Neoplasms 106 125.53 84.4 70.3 101.4
Female Corporate Mortality File deaths compated to female U.S. cancer deaths, 1969–2001.
† = p < 0.05Page 7 of 10
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what more elevated in the manufacturing workers. The
decreased mortality due to respiratory system cancer in
males in the CMF was similar in the manufacturing sub-
group. However, all the manufacturing subgroup analyses
were based on fewer deaths and were therefore statistically
less stable. In males employed in manufacturing, there
was consistent increased mortality from cancer of diges-
tive organs, kidney cancer, melanoma of skin and cancer
of the brain and central nervous system. The PCMRs for
several of these cancers were significantly elevated and
there was also excess mortality due to non-Hodgkin's lym-
phoma within the broader category of lymphatic and
hematopoietic malignancies. Among female manufactur-
ing workers, we found the breast cancer PMR to be slightly
elevated, while the PMRs for kidney cancer and lymphatic
and hematopoietic tissue malignancies were significantly
elevated but based on few deaths. The female manufactur-
ing workers PCMRs were based on very few deaths and
followed a similar pattern.
Mortality analyses such as the one we conducted are lim-
ited by the availability of information on death certifi-
cates, and typically this does not permit controlling for
confounding factors such as prior occupational exposures,
non-occupational exposures, or cigarette smoking [14].
Similarly, the cause of death information is often limited
and may be incomplete for certain types of cancer. These
limitations are well-documented and apply to these CMF
analyses, as well. Work history information available for
grouping manufacturing workers or locations was also
incomplete, but we did not detect any systematic pattern
in the missing data that would produce biased estimates
of effect. We examined the overall patterns of mortality
among those for whom work history information was
available and they appeared to be similar to those for
Table 6: Cause-Specific Proportional Cancer Mortality Ratios (PCMRs) for Male Manufacturing Workers
Cause Of Death Observed Expected PCMR 95% CI
All Malignant Neoplasms 1,180 1,180.00 100.0 --- ---
Cancer of Buccal Cavity & Pharynx 20 30.79 64.9† 42.3 99.7
Cancer of Digestive Organs & Peritoneum 303 287.11 105.5 95.7 116.4
Cancer of Esophagus 38 41.54 91.5 67.0 125.0
Cancer of Stomach 35 35.12 99.6 71.9 138.1
Cancer of Large Intestine 91 93.08 97.8 80.3 119.1
Cancer of Rectum 27 19.38 139.3 96.0 202.1
Cancer of Biliary Passages & Liver 29 32.90 88.1 61.6 126.1
Cancer of Pancreas 73 57.99 125.9† 100.7 157.4
Cancer of All Other Digestive Organs 10 6.99 143.1 77.4 264.7
Cancer of Respiratory System 389 464.42 83.8† 77.6 90.4
Cancer of Larynx 7 16.29 43.0† 21.0 87.8
Cancer of Trachea, Bronchus, & Lung 378 444.16 85.1† 78.6 92.1
Cancer of All Other Respiratory Organs 4 3.96 100.9 37.9 268.3
Cancer of Breast 2 1.42 140.9 35.5 559.2
Cancer of Prostate 77 68.98 111.6 90.1 138.3
Cancer of Testes & Other Male Genital Organs 2 2.99 66.8 17.1 260.9
Cancer of Kidney 51 31.49 162.0† 123.9 211.8
Cancer of Bladder & Other Urinary Organs 23 22.36 102.9 68.7 154.2
Malignant Melanoma of Skin 38 21.23 179.0† 131.4 243.9
Cancer of Eye 0 .58 --- --- ---
Cancer of Brain and Other Central Nervous System 57 34.45 165.5† 128.6 212.9
Cancer of Thyroid & Other Endocrine Glands 4 3.34 119.9 45.1 318.6
Cancer of Bone 2 2.56 78.1 19.7 308.9
Cancer of All Lymphatic, Hematopoietic Tissue 115 109.46 105.1 88.4 124.9
Lymphosarcoma & Reticulosarcoma 8 5.14 155.7 78.6 308.4
Hodgkin's Disease 2 4.89 40.9 10.9 153.9
Leukemia & Aleukemia 35 39.94 87.6 63.4 121.2
Cancer of All Other Lymphopoietic Tissue 70 59.49 117.7 93.7 147.8
Non-Hodgkin's Lymphoma 56 44.42 126.1 97.6 162.8
Multiple Myeloma 21 19.55 107.4 70.3 164.1
All Other Malignant Neoplasms 97 98.93 98.1 81.1 118.6
Male Corporate Mortality File manufacturing worker deaths compared to male U.S. cancer deaths, 1969–2001.
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we do not consider the manufacturing analyses to be dis-
torted in any important way; the lack of information
reduces the number of deaths available for inclusion in
these analyses and therefore reduces the power to detect
some associations.
As noted above, this study was conducted in the context of
litigation, so we were unable to communicate with the
record providers to clarify inconsistencies or fill gaps in
the information provided. Here again, we do not consider
this to be a significant source of bias, but it limits the
power of the sub-group analyses. If additional work is car-
ried out on this database, it would be desirable to do this
in an atmosphere of open communication.
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